Molecular abnormalities in B-cell chronic lymphocytic leukaemia

Clinical and Laboratory Haematology

Volumn 23, Issue 3, 2001, Pages 139-148

  Fegan, Christopher ^a  

^a Department of Haematology ^*  (United Kingdom)

Author keywords

ATM; Chromosome 11; Chromosome 13; Chronic lymphocytic leukaemia; Karyotype; p53

Indexed keywords

ATM PROTEIN; PROTEIN P53;

ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; B CELL LEUKEMIA; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 18; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CODON; DISEASE SEVERITY; GENE SEQUENCE; HUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEQUENCE ANALYSIS; TRISOMY 12; TUMOR SUPPRESSOR GENE;

CELL CYCLE PROTEINS; CHROMOSOME ABERRATIONS; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MUTATION; ONCOGENES; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 0035724649     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2001.00395.x     Document Type: Review

References (107)

1. Varient translocation of Bcl-2 gene to immunoglobulin lambda light chain in chronic lymphocytic leukaemia
2. Juxtaposition of human Bcl-2 and immunoglobulin light chain gene in chronic lymphocytic leukaemia is the result of a reciprocal chromosome translocation between chromosome 18 and 22
3. Preferential linkage of Bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukaemia
4. Monoallelic p53 deletion in chronic lymphocytic leukaemia detected by interphase cytogenetics
5. The sequential analysis of trisomy 12 in B-cell chronic lymphocytic leukaemia
6. Exon-intron structure of a LEU 5 gene belonging to the Rfp family and located in the 13q14.3 region is often deleted in B-CLL
7. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia
8. Chromosome aberrations in atypical chronic lymphocytic leukaemia: A cytogenetic and interphase cytogenetic study
9. Translocation t (11; 14) (q13; q32) in chronic lymphoid disorders
10. P53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia
11. ATM mutations in B-cell chronic lymphocytic leukaemia
12. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukaemia
13. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a critical gene in leukaemogenesis in chronic B-cell lymphocytic leukaemia
14. Detailed molecular deliniation of 13q14.3 loss in B-cell chronic lymphocytic leukaemia
15. p53 expression in B-cell chronic lymphocytic leukaemia: A marker of disease progression and poor prognosis
16. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemia
17. Further characterization of morphologically defined typical and atypical CLL: A clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases
18. Atypical chronic lymphocytic leukaemia with t (11; 14) (q13; q32): Karyotype evolution and prolymphocytic transformation
19. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia
20. Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukaemia and accurate mapping of the involved tumour suppressor gene
21. FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial Trisomy 12
22. P53 gene deletion predicts for poor survival and non-response to therapy with purine analogues in chronic B-cell leukaemias
23. Genomic aberrations and survival in chronic lymphocytic leukaemia
24. 11q deletions identify a new subset of B-cell chronic lymphocytic leukaemia characterized by extensive nodal involvement and inferior prognosis
25. Bcl-2 translocations in leukaemias of mature B-cells
26. P53 mutations in B-cell chronic lymphocytic leukaemia
27. P53 gene mutation in B-cell chronic lymphocytic leukaemia is associated with drug resistance and is independent of MDR-1/MDR-3 gene expression
28. Karyotypic evolution in CLL: Identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease
29. Mutations of the p53 gene in b-cell chronic lymphocytic leukaemia: A report of 39 cases with cytogenetic analysis
30. Chronic Leukaemias
31. Chromosome abnormalities involving band 13q14 in haematological malignancies
32. Cytogenetic mapping of the duplicated segment of chromosome 12 in lymphoproliferative disorders
33. P53 mutations in human lymphoid malignancies: Association with Burkitt's lymphoma and chronic lymphocytic leukaemia
34. Analysis of alterations of oncogenes and tumour suppressor genes in chronic lymphocytic leukaemia
35. Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia
36. Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukaemia
37. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukaemia
38. Inactivation of the retinoblastoma gene in human lymphoid neoplasms
39. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia
40. Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukaemia
41. The consistent 13q14 translocation break point seen in chronic B-cell leukaemia (BCLL) involved deletions of the D13S25 locus which lies distal to the retinoblastoma predisposition gene
42. Cytogenetic analysis of B cell chronic lymphocytic leukaemia classified according to morphologic and immunophenotypic (FAB) criteria
43. Anticipation in familial leukaemia
44. Rearrangement and expression of MDM2 oncogene in chronic lymphocytic leukaemia
45. The human homologue of the Drosophilia tail-less gene (TLX): Characterisation and mapping to a region of common deletion in human lymphoid leukaemia on chromosome 6q21
46. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukaemia and leukaemic immunocytoma
47. Prognostic sub-groups in B-cell chronic lymphocytic leukaemia defined by specific chromosomal abnormalities
48. Cytogenetic findings and survival in B-cell chronic lymphocytic leukaemia. Second IWC CLL compilation of data on 622 patients
49. Chromosome abnormalities and RB-1 gene deletion in chronic lymphocytic leukaemia
50. Cytogenetics in CLL and related disorders
51. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukaemia
52. A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene
53. Frequent loss of the 11q14-24 region in chronic lymphocytic leukaemia; a study by comparative genomic hybridization genes
54. Confirmation of Rb gene defect in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone
55. Expression of apoptosis-regulating proteins in chronic lymphocytic leukaemia. Correlation with in vitro and in vivo chemo-responses
56. P53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis
57. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukaemia
58. 13q deletions in lymphoid malignancies
59. Retinoblastoma gene deletions in B-cell chronic lymphocytic leukaemia
60. Lymphocytic leukaemia cells with deletions at 13q14 commonly have one intact RB-1 gene: Evidence for role of an adjacent locus
61. 13q14 deletions are not the primary events in B-cell chronic lymphocytic leukaemia: A study of 100 patients using fluorescence in situ hybridisation
62. The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
63. Identification of a transcriptional unit adjacent to the breakpoint in the 14; 19 translocation of chronic lymphocytic leukaemia
64. Cloning of the chromosome translocation breakpoint junction of the t (14; 19) in chronic lymphocytic leukaemia
65. Bcl-3 rearrangements and t(14; 19) in chronic lymphocytic leukaemia and other B cell malignancies: A molecular and cytogenetic study
66. Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia
67. Bcl-3 rearrangement and t (14; 19) (q32; q13) in lymphoproliferative disorders
68. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukaemia
69. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival
70. Mantle cell leukaemia
71. Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukaemia
72. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del 6 (Q21; Q23)
73. Amplification of a gene encoding a p53-associated protein in human sarcoma
74. Cytogenetic studies in splenic lymphoma with villous lymphocytes
75. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia
76. Lack of clonal BRCA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia
77. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2 expressing clones
78. Aberration of chromosome 6 in 193 newly diagnosed untreated cases of chronic lymphocytic leukaemia
79. Prognostic significance of chromosome abnormalities in chronic lymphocytic leukaemia
80. Trisomy 12 in chronic lymphocytic leukaemia detected by fluorescence in-situ hybridisation: Analysis by stage immunophenotype and morphology
81. Oncogene rearrangements in chronic B-cell leukaemia
82. Chronic lymphocytic leukaemia in the elderly
83. A search for Bcl-1, Bcl-2 and c-myc oncogene rearrangements in chronic lymphocytic leukaemia
84. Lack of MDM-2 amplification in human leukaemia
85. Exclusion of Leu 1 and Leu 2 genes as a tumor suppressor genes in 13q14.3 deleted B-CLL
86. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukaemia
87. Growth and differentiation associated expression of Bcl-2 in B-cell chronic lymphocytic leukaemia
88. Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within 2 megabase segment of 6q21
89. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
90. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukaemia
91. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukaemia
92. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphocytic leukaemia shown by interface cytogenetics
93. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders
94. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukaemia revealed by fluorescence in situ hybridization
95. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukaemia and mantle cell lymphoma
96. Biallelic mutations in the ATM gene in T- prolymphocytic leukaemia
97. Inactivation of the ATM gene in T-cell prolymphocytic leukaemia
98. Cytogenetic 2; 18 and 18, 22 translocation in chronic lymphocytic leukaemia with juxtaposition of Bcl-2 and immunoglobulin light chain genes
99. Leukaemia and lymphoma in ataxia telangiectasia
100. 14; 19 Translocation in B-cell chronic lymphocytic leukaemia: A new recurring chromosome aberration
101. Clustering of missense mutations in ataxia telangiectasia gene in sporadic T cell leukaemia
102. The MDM-2 oncogene overexpression in chronic lymphocytic leukaemia and low grade lymphoma of B cell origin
103. P53 mutations are associated with resistance to chemotherapy and short survival in haematologic malignancies
104. ATM and p53 co-operate in apoptosis and suppression of tumorigenesis but not in resistance to acute radiation, toxicity
105. Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukaemia